Khan Siddiqui - Mar 29, 2022 Form 4 Insider Report for Hyperfine, Inc. (HYPR)

Role: CMO and Chief Strategy Officer
Signature: /s/ Neela Paykel, Attorney-in-Fact
Stock symbol: HYPR
Transactions as of: Mar 29, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/31/2022, 06:07 PM
Previous filing: Feb 11, 2022
Next filing: Jul 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HYPR	Class A Common Stock	Award	$0	+55K		$0.00	55K	Mar 29, 2022	Direct	F1
transaction	HYPR	Class A Common Stock	Award	$0	+37K	+67.27%	$0.00	92K	Mar 29, 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this restricted stock unit ("RSU") vest as to 25% on the grant date, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning February 15, 2021; provided that any vesting of the award will be delayed until July 1, 2022, and the number of RSUs vesting on the first scheduled vesting date following July 1, 2022 will also include any delayed vesting RSUs, subject to Dr. Siddiqui's continued service through the applicable vesting date.
F2	The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.

Content

The shares underlying this restricted stock unit ("RSU") vest as to 25% on the grant date, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over three years beginning February 15, 2021; provided that any vesting of the award will be delayed until July 1, 2022, and the number of RSUs vesting on the first scheduled vesting date following July 1, 2022 will also include any delayed vesting RSUs, subject to Dr. Siddiqui's continued service through the applicable vesting date.

The shares underlying this RSU vest as to 25% on March 20, 2023, and the remainder in equal quarterly installments at the mid-point of each calendar quarter over the following three years, beginning on May 15, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date.